Involuntary treatment of schizophrenia patients 2004-2010 in Denmark

Acta Psychiatrica Scandinavica

Volumn 129, Issue 4, 2014, Pages 312-319

  Andersen, T H ^a   Kappers, D ^a   Sneider, B ^a   Uggerby, P ^a   Nielsen, J ^a  

^a Aalborg Psykiatriske Sygehus   (Denmark)

Author keywords

Antipsychotic; Clozapine; ECT; Involuntary treatment; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL PRACTICE; DENMARK; DRUG USE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; INVOLUNTARY COMMITMENT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; SCHIZOPHRENIA; EPIDEMIOLOGY; FORENSIC PSYCHIATRY; MIDDLE AGED; REGISTER; STATISTICS AND NUMERICAL DATA;

ADULT; ANTIPSYCHOTIC AGENTS; COMMITMENT OF MENTALLY ILL; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; SCHIZOPHRENIA;

EID: 84896043827     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12144     Document Type: Article

References (42)

1. Ingason A, Giegling I, Cichon S, et al. A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum Mol Genet 2010;19:1379-1386.
2. Uggerby P, Nielsen RE, Correll CU, Nielsen J. Characteristics and predictors of long-term institutionalization in patients with schizophrenia. Schizophr Res 2011;131:120-126.
3. Lang FU, Kosters M, Lang S, Becker T, Jager M. Psychopathological long-term outcome of schizophrenia - a review. Acta Psychiatr Scand 2013;127:173-182.
4. Breslau J, Miller E, Jin R, et al. A multinational study of mental disorders, marriage, and divorce. Acta Psychiatr Scand 2011;124:474-486.
5. Bennett DJ, Ogloff JR, Mullen PE, Thomas SD, Wallace C, Short T. Schizophrenia disorders, substance abuse and prior offending in a sequential series of 435 homicides. Acta Psychiatr Scand 2011;124:226-233.
6. Hoang U, Goldacre MJ, Stewart R. Avoidable mortality in people with schizophrenia or bipolar disorder in England. Acta Psychiatr Scand 2013;127:195-201.
7. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 2005;62:247-253.
8. Vancampfort D, Knapen J, Probst M, Scheewe T, Remans S, de Hert M. A systematic review of correlates of physical activity in patients with schizophrenia. Acta Psychiatr Scand 2012;125:352-362.
9. Nielsen J, Munk-Jorgensen P, Skadhede S, Correll CU. Determinants of poor dental care in patients with schizophrenia: a historical, prospective database study. J Clin Psychiatry 2011;72:140-143.
10. Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S, Lieberman JA. Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia. Schizophr Bull 2009;35:336-346.
11. Jarrett M, Bowers L, Simpson A. Coerced medication in psychiatric inpatient care: literature review. J Adv Nurs 2008;64:538-548.
12. Gutierrez-Casares JR, Canas F, Rodriguez-Morales A, Hidalgo-Borrajo R, Alonso-Escolano D. Adherence to treatment and therapeutic strategies in schizophrenic patients: the ADHERE study. CNS Spectr 2010;15:327-337.
13. Jonsdottir H, Opjordsmoen S, Birkenaes AB, et al. Predictors of medication adherence in patients with schizophrenia and bipolar disorder. Acta Psychiatr Scand 2013;127:23-33.
14. Opsal A, Clausen T, Kristensen O, Elvik I, Joa I, Larsen TK. Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up. Acta Psychiatr Scand 2011;124:198-204.
15. Cougnard A, Kalmi E, Desage A, et al. Factors influencing compulsory admission in first-admitted subjects with psychosis. Soc Psychiatry Psychiatr Epidemiol 2004;39:804-809.
16. Montemagni C, Bada A, Castagna F, et al. Predictors of compulsory admission in schizophrenia-spectrum patients: excitement, insight, emotion perception. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:137-145.
17. Steinert T, Lepping P, Baranyai R, Hoffmann M, Leherr H. Compulsory admission and treatment in schizophrenia: a study of ethical attitudes in four European countries. Soc Psychiatry Psychiatr Epidemiol 2005;40:635-641.
18. Nordt C, Rossler W, Lauber C. Attitudes of mental health professionals toward people with schizophrenia and major depression. Schizophr Bull 2006;32:709-714.
19. Lauber C, Nordt C, Falcato L, Rossler W. Public attitude to compulsory admission of mentally ill people. Acta Psychiatr Scand 2002;105:385-389.
20. Swartz MS, Swanson JW, Hannon MJ. Does fear of coercion keep people away from mental health treatment? Evidence from a survey of persons with schizophrenia and mental health professionals. Behav Sci Law 2003;21:459-472.
21. Nielsen J, Nielsen RE, Correll CU. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study. J Clin Psychopharmacol 2012;32:678-683.
22. Mors O, Perto GP, Mortensen PB. The Danish Psychiatric Central Research Register. Scand J Public Health 2011;39:54-57.
23. Munk-Jorgensen P, Ostergaard SD. Register-based studies of mental disorders. Scand J Public Health 2011;39:170-174.
24. Hollis C. Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity. Am J Psychiatry 2000;157:1652-1659.
25. Nielsen J, le Quach P, Emborg C, Foldager L, Correll CU. 10-Year trends in the treatment and outcomes of patients with first-episode schizophrenia. Acta Psychiatr Scand 2010;122:356-366.
26. Barnes TR. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2011;25:567-620.
27. Taylor DM, Smith L, Gee SH, Nielsen J. Augmentation of clozapine with a second antipsychotic - a meta-analysis. Acta Psychiatr Scand 2012;125:15-24.
28. Schulte PF, Stienen JJ, Bogers J, et al. Compulsory treatment with clozapine: a retrospective long-term cohort study. Int J Law Psychiatry 2007;30:539-545.
29. Nielsen J, Damkier P, Lublin H, Taylor D. Optimizing clozapine treatment. Acta Psychiatr Scand 2011;123:411-422.
30. Buchanan RW, Kreyenbuhl J, Kelly DL, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010;36:71-93.
31. Nielsen J, Roge R, Schjerning O, Sorensen HJ, Taylor D. Geographical and temporal variations in clozapine prescription for schizophrenia. Eur Neuropsychopharmacol 2012;22:818-824.
32. Nielsen J, Dahm M, Lublin H, Taylor D. Psychiatrists' attitude towards and knowledge of clozapine treatment. J Psychopharmacol 2010;24:965-971.
33. Nielsen J, Foldager L, Meyer JM. Increased use of antibiotics in patients treated with clozapine. Eur Neuropsychopharmacol 2009;19:483-486.
34. McEvoy JP, Lieberman JA, Stroup TS, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry 2006;163:600-610.
35. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev 2005:CD000076.
36. Chanpattana W, Kramer BA. Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes. Schizophr Res 2003;63:189-193.
37. Adams CE, Fenton MK, Quraishi S, David AS. Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. Br J Psychiatry 2001;179:290-299.
38. Agid O, Foussias G, Remington G. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention. Expert Opin Pharmacother 2010;11:2301-2317.
39. Kisely S, Campbell LA, Preston N. Compulsory community and involuntary outpatient treatment for people with severe mental disorders. Cochrane Database Syst Rev 2005;123:CD004408.
40. Steinert T, Schmid P. Effect of voluntariness of participation in treatment on short-term outcome of inpatients with schizophrenia. Psychiatr Serv 2004;55:786-791.
41. Hamann J, Mendel RT, Fink B, Pfeiffer H, Cohen R, Kissling W. Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment. J Nerv Ment Dis 2008;196:329-332.
42. Pinfold V, Bindman J, Thornicroft G, Franklin D, Hatfield B. Persuading the persuadable: evaluating compulsory treatment in England using Supervised Discharge Orders. Soc Psychiatry Psychiatr Epidemiol 2001;36:260-266.